Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04678947 · ClinicalTrials.gov registry record · NA
The BARF Project: A Pilot Study Using the BARF Scale to Assess CINV in Children
A NA study, sponsored by Washington University School of Medicine.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT04678947: Clinical Trial NA study, sponsored by Washington University School of Medicine.
NCT04678947 is a NA study that was terminated before completion, run by Washington University School of Medicine. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04678947, a NA study, was terminated before completion, sponsored by Washington University School of Medicine.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
In this pilot study, the Baxter Retching Faces (BARF) Scale will be used to assess chemotherapy induced nausea and vomiting (CINV) in the pediatric cancer population during chemotherapy admissions, and the corresponding administration of anti-emetic medications will be reviewed.
Interventions
- BEHAVIORAL Baxter Retching Faces (BARF) scale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2021-03-17 |
| Est. Completion | 2021-03-25 |
| Phase | NA |
Why NCT04678947 stopped before completion
NCT04678947 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Baxter Retching Faces (BARF) scale is the first listed.
NCT04678947 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04678947 about?
NCT04678947 is a clinical study titled "The BARF Project: A Pilot Study Using the BARF Scale to Assess CINV in Children". In this pilot study, the Baxter Retching Faces (BARF) Scale will be used to assess chemotherapy induced nausea and vomiting (CINV) in the pediatric cancer population during chemotherapy admissions, and the corresponding administration of anti-emetic medications will be reviewed.
What is the current status of trial NCT04678947?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2021-03-17. Estimated completion is 2021-03-25.
What interventions are being tested in trial NCT04678947?
The interventions under investigation include: Baxter Retching Faces (BARF) scale (BEHAVIORAL).
Who is sponsoring clinical trial NCT04678947?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04678947's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI